News Search Results
Aug 16, 2024, 17:00 ET WesternU COMP and COMP-Northwest ranked in U.S. News & World Report's top tier for primary care
Calif. and Lebanon, Ore., is an independent nonprofit health professions university, conferring degrees in biotechnology and pharmaceutical sciences, dental medicine, medical sciences, nursing, optometry, osteopathic medicine, pharmacy, physical therapy, physician
More news about: Western University of Health Sciences
Aug 16, 2024, 16:15 ET Lilly announces retirement of Marschall S. Runge from its Board of Directors
life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Aug 16, 2024, 08:38 ET Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Aug 16, 2024, 04:07 ET Shoolini Redefines Standards for Young Universities
Founder-Chancellor, Prof PK Khosla. About Shoolini University Set up in 2009, Shoolini University of Biotechnology and Management Sciences is a research-driven private university with full recognition from the UGC. As the No.1 Private University in India
More news about: Shoolini University
Aug 15, 2024, 18:00 ET Sanyou Bio's Innovative Intelligent Antibody Design oneClick+ Platform is Officially Launched
support of intelligent technology!" About Sanyou Biopharmaceuticals Sanyou Biopharmaceuticals Co., Ltd. is a world-leading high-tech biotechnology enterprise focusing on R&D and services of innovative biologic drugs. Sanyou has built the 4C business patterns that integrate "differentiated
More news about: Sanyou Bio
Aug 15, 2024, 18:00 ET Visionary Holdings Inc. Reports Fiscal Year 2024 Financial Results
resignation did not result from any disagreement or disputes with the Company. On March 11, 2024, Visionary Biotechnology Group Inc., the joint venture company, was incorporated in Toronto, Ontario. On March
More news about: Visionary Holdings Inc.
Aug 15, 2024, 16:45 ET Armata Pharmaceuticals Announces Appointment of Life Sciences Accounting and Finance Veteran David House as SVP of Finance and Principal Financial Officer
Aug. 15, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat
More news about: Armata Pharmaceuticals, Inc.
Aug 15, 2024, 13:00 ET TC BioPharm Regains Compliance with Nasdaq Listing Rule 5550(b)
Aug. 15, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that the Company has regained
More news about: TC BioPharm
Aug 15, 2024, 11:30 ET TC BioPharm Announces Closing of $2.0 Million Public Offering
Aug. 15, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced the closing of its previously
More news about: TC BioPharm
Aug 15, 2024, 10:01 ET DNA Sequencing Market to Be Worth $21.30 Billion by 2031--Exclusive Report by Meticulous Research®
2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of 44.7% of the DNA sequencing market. This segment's large market share can be attributed to the increasing R&D spending by pharmaceutical & biotechnology companies, the growing utilization
More news about: Meticulous Market Research Pvt. Ltd.
Aug 15, 2024, 08:45 ET Cresilon Receives FDA Clearance for TRAUMAGEL
Aug. 15, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has received U.S. Food and Drug Administration ("FDA") 510(k) clearance
More news about: Cresilon
Aug 15, 2024, 08:45 ET Cresilon Receives FDA Clearance for TRAUMAGEL
YORK, Aug. 15, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has received U.S. Food and Drug Administration ("FDA") 510(k) clearance
More news about: Cresilon
Aug 15, 2024, 08:31 ET Anbio Biotechnology Unveils Comprehensive In-Vitro-Diagnostics Solutions at ADLM 2024
Anbio Biotechnology Anbio Biotechnology is devoted to make contributions for human health and has never stopped our goal to innovate in life sciences. Driven by continuous
More news about: Anbio Biotechnology
Aug 14, 2024, 17:45 ET Chromatography Market size is set to grow by USD 3.99 billion from 2024-2028, Increasing number of conferences and symposiums to boost the market growth, Technavio
for advanced and automated systems. These systems offer improved accuracy, efficiency, and lower costs, making them essential for sectors like biotechnology and pharmaceuticals. Automated chromatography technologies have revolutionized research centers by enabling advancements in cancer research, drug
More news about: Technavio
Aug 14, 2024, 17:30 ET Drag Reducing Agent Market size is set to grow by USD 93.1 million from 2024-2028, Increasing application of drag reducing agents in oil and gas industry to boost the market growth, Technavio
fluid flow, resulting in increased pipeline efficiency and lower energy costs. Biotechnology, on the other hand, involves utilizing living organisms to produce new products. In the context of drag-reducing agents, biotechnology could lead to the development of renewable and biodegradable agents, offering
More news about: Technavio
Aug 14, 2024, 16:01 ET NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update
treatments, including ketamine-focused treatment for depression and suicidality. Unlike the core business of NRx Pharmaceuticals, that is focused on biotechnology Research and Development, HOPE is organized around consolidating existing best-in-class clinics into a nationwide network. This has been done previously
More news about: NRx Pharmaceuticals, Inc.
Aug 14, 2024, 12:30 ET Exosomes Skincare Market Size to Grow USD 674.2 Million by 2030 at a CAGR of 9.6% | Valuates Reports
Driving the Growth of Exosomes Skincare Market: The market for exosome skincare products is expanding significantly due to advances in biotechnology and rising consumer awareness of cutting-edge skincare products. Nanoscale extracellular vesicles called exosomes have been shown to improve skin
More news about: Valuates Reports
Aug 14, 2024, 10:01 ET Biopharmaceutical Processing Equipment and Consumables Market to be Worth $75.72 Billion by 2031- Exclusive Report by Meticulous Research®
Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy). The global biopharmaceutical processing equipment and consumables market is segmented by product
More news about: Meticulous Market Research Pvt. Ltd.
Aug 14, 2024, 09:50 ET Examining the Role of AI in Advancing Healthcare Efficiency
tech company Avant Technologies Inc. (OTCQB: AVAI) developing solutions in AI infrastructure while exploring additional technologies in the biotechnology and healthcare sectors, recently announced a significant initiative to improve patient care through advanced AI-powered healthcare infrastructure.
More news about: USA News Group
Aug 14, 2024, 08:01 ET NeuroBo Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Update
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the second quarter ended June
More news about: NeuroBo Pharmaceuticals, Inc.
Aug 14, 2024, 08:00 ET Veridix AI, part of Emmes Group, Announces New Protocol Digitization Capabilities
Emmes CRO has supported more than 2,000 clinical trials across numerous agencies and institutes of the U.S. federal government and a wide range of biotechnology, pharmaceutical and medical device companies throughout the world. The company has built industry leading capabilities in cell and gene therapy,
More news about: EMMES
Aug 14, 2024, 08:00 ET Veridix AI, part of Emmes Group, Announces New Protocol Digitization Capabilities
Emmes CRO has supported more than 2,000 clinical trials across numerous agencies and institutes of the U.S. federal government and a wide range of biotechnology, pharmaceutical and medical device companies throughout the world. The company has built industry leading capabilities in cell and gene therapy,
More news about: EMMES
Aug 14, 2024, 07:45 ET ImmPACT Bio Appoints Ian Somaiya to its Board of Directors
esteemed equity analyst who conducted extensive research on more than 100 biotechnology companies across diverse therapeutic areas, technology platforms, and stages of development. He served as a managing director and head of biotechnology research at BMO Capital Markets and as managing director and equity
More news about: ImmPACT Bio USA Inc.
Aug 14, 2024, 07:29 ET Prota Therapeutics Announces Publication in Allergy of Long-Term Peanut Allergy Study Confirming Clinical Remission as the Optimal Treatment Outcome
Prota Therapeutics Pty Ltd (Prota), an Australian clinical-stage biotechnology company focused on the development of novel oral immunotherapy treatments that induce remission of allergy, today announced publication in the journal
More news about: Prota Therapeutics
Aug 14, 2024, 05:48 ET Shoolini University Leads in Tech Education with AI & Industry Alliances
Virender Rihani added. About Shoolini University Set up in 2009, Shoolini University of Biotechnology and Management Sciences is a research-driven private university with full recognition from the UGC. As the No.1 Private University in India
More news about: Shoolini University